EP0647138A4 - Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same. - Google Patents

Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same.

Info

Publication number: EP0647138A4
Authority: EP; European Patent Office
Prior art keywords: fasciola; vaccines; species; treatment; methods
Prior art date: 1993-02-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP94906095A

Other languages

German (de)

French (fr)

Other versions

EP0647138A1 (en

Inventor

Andrew Richard Milner

Michel Panaccio

Terence William Spithill

Gene Louise Wijffels

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Agriculture Victoria Services Pty Ltd

Original Assignee

Daratech Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-05

Filing date

1994-02-04

Publication date

1996-03-06

1994-02-04 Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd

1995-04-12 Publication of EP0647138A1 publication Critical patent/EP0647138A1/en

1996-03-06 Publication of EP0647138A4 publication Critical patent/EP0647138A4/en

Status Withdrawn legal-status Critical Current

Links

108091028043 Nucleic acid sequence Proteins 0.000 title 1
241000242541 Trematoda Species 0.000 title 1
229920001184 polypeptide Polymers 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
241000894007 species Species 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/641—Cysteine endopeptidases (3.4.22)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

EP94906095A 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same. Withdrawn EP0647138A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AUPL7109/93		1993-02-05
AUPL710993		1993-02-05
PCT/AU1994/000051 WO1994017820A1 (en)	1993-02-05	1994-02-04	Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same

Publications (2)

Publication Number	Publication Date
EP0647138A1 EP0647138A1 (en)	1995-04-12
EP0647138A4 true EP0647138A4 (en)	1996-03-06

Family

ID=3776688

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP94906095A Withdrawn EP0647138A4 (en)	1993-02-05	1994-02-04	Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same.

Country Status (8)

Country	Link
EP (1)	EP0647138A4 (en)
JP (1)	JPH07505787A (en)
AU (1)	AU5996294A (en)
BR (1)	BR9404004A (en)
CA (1)	CA2126455A1 (en)
NO (1)	NO942360L (en)
NZ (1)	NZ261279A (en)
WO (1)	WO1994017820A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0721466A1 (en) *	1993-09-28	1996-07-17	The University Of Melbourne	Protective antigens against parasites
NZ337697A (en)	1997-03-11	2001-06-29	Stichting Dienst Landbouwkundi	An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
AU2002239753A1 (en) *	2000-10-18	2002-05-21	Incyte Genomics, Inc.	Proteases
SI1543038T2 (en)	2002-09-11	2020-12-31	Genentech, Inc.	Protein purification
PL201419B1 (en) *	2002-12-04	2009-04-30	Inst Biotechnologii I Antybiot	Chimeric protein, sequence, construction, vegetable cell, method of obtaining chimeric protein and transgenic plant, transgenic plant, application of transgenic plant and chimeric protein
PL196114B1 (en) *	2002-12-31	2007-12-31	Inst Biotechnologii I Antybiot	Inclusion bodies as antigenes in oral immunization of animals
BR112012008185A2 (en) *	2009-10-07	2016-08-16	Wyeth Llc	compositions comprising adjuvant, macrolide and proteinaceous antigen, and methods for use of such compositions
ES2525106B1 (en) *	2013-06-17	2015-09-29	Universidad De Salamanca	Synthetic peptide derived from Fasciola hepatica and its use as a vaccine
GB201714057D0 (en) *	2017-09-01	2017-10-18	Univ College Dublin Nat Univ Of Ireland Dublin	A fasciola hepatica antigen and vaccine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0524834A2 (en) *	1991-07-25	1993-01-27	Fusanori Hamajima	Immunosuppressive drugs containing a cysteine protease
WO1994009142A1 (en) *	1992-10-21	1994-04-28	Mallinckrodt Veterinary, Inc.	Vaccine containing a thiol protease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8432401D0 (en) *	1984-12-21	1985-02-06	Bennett C E	Liver fluke antigens
AU7871987A (en) *	1986-08-18	1988-03-08	Australian National University, The	Helminth parasite vaccine
CA2045663A1 (en) *	1989-01-31	1990-08-01	Sonia Louise Crameri	Vaccine for the preventative treatment of infection of liver fluke in ruminants

1994
- 1994-02-04 WO PCT/AU1994/000051 patent/WO1994017820A1/en not_active Ceased
- 1994-02-04 EP EP94906095A patent/EP0647138A4/en not_active Withdrawn
- 1994-02-04 JP JP6517444A patent/JPH07505787A/en active Pending
- 1994-02-04 NZ NZ261279A patent/NZ261279A/en unknown
- 1994-02-04 CA CA002126455A patent/CA2126455A1/en not_active Abandoned
- 1994-02-04 BR BR9404004A patent/BR9404004A/en not_active Application Discontinuation
- 1994-02-04 AU AU59962/94A patent/AU5996294A/en not_active Abandoned
- 1994-06-21 NO NO942360A patent/NO942360L/en unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0524834A2 (en) *	1991-07-25	1993-01-27	Fusanori Hamajima	Immunosuppressive drugs containing a cysteine protease
WO1994009142A1 (en) *	1992-10-21	1994-04-28	Mallinckrodt Veterinary, Inc.	Vaccine containing a thiol protease

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
A.J.DOWD ET AL.: "Purification and Characterization of a cysteine Proteinase secreted from Fasciola hepatica", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 20, no. 1, UK, pages 86S *
C.CARMORA ET AL: "A Fasciola hepatica Cathepsin L proteinase prevents the adherence of eosinophils to newly excysted juvenils", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 20, no. 1, UK, pages 85S, XP001316943 *
H.YAMASAKI ET AL.: "A Cysteine Proteinase from the Liver Fluke Fasciola spp.: Purification, Characterization, Lacalization and Application to Immunodiagnosis", JPN.J.PARASITOL., vol. 38, no. 6, pages 373 - 84 *
H.YAMASAKI ET AL.: "Cloning and Sequence Analysis of the Major Cysteine Protease Expressed in the Tetramode Parasite Fasciola SP.", BIOCHEMIST,MOLECUL.BIOL.INT., vol. 31, no. 3, pages 537 - 42 *
M.-Q. KLINKERT ET AL.: "Primary structures of SM31/32 diagnostic proteins of S.mansoni and their identification as proteases", MOL.BIOCHEM.PARASITOL., vol. 33, pages 113 - 22, XP023887855, DOI: doi:10.1016/0166-6851(89)90025-X *
See also references of WO9417820A1 *

Also Published As

Publication number	Publication date
AU5996294A (en)	1994-08-29
NO942360L (en)	1994-10-05
BR9404004A (en)	1999-05-25
WO1994017820A1 (en)	1994-08-18
NO942360D0 (en)	1994-06-21
JPH07505787A (en)	1995-06-29
NZ261279A (en)	1996-03-26
CA2126455A1 (en)	1994-08-06
EP0647138A1 (en)	1995-04-12

Legal Events

Date	Code	Title	Description
1995-02-24	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-04-12	17P	Request for examination filed	Effective date: 19940906
1995-04-12	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1996-03-06	A4	Supplementary search report drawn up and despatched	Effective date: 19960118
1996-03-06	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1996-04-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
1996-05-22	18W	Application withdrawn	Withdrawal date: 19960327

Publication	Publication Date	Title
NO911694D0 (en)	1991-04-29	MICROEMULUS MIXTURE FOR HAIR TREATMENT, PROCEDURE FOR MANUFACTURING AND USING THEREOF.
HUP9802217A3 (en)	1999-09-28	Recombinant mva virus, and the use thereof
EP0677927A3 (en)	1997-06-11	Character string pattern matching for compression and the like using minimal cycles per character.
ZA972929B (en)	1997-11-03	Systems for the treatment of commingled wastes and methods for treating commingled wastes.
ZA971259B (en)	1997-12-04	Antimicrobial peptides and methods of use.
ZA200110161B (en)	2002-09-30	Anti-avB3 recombinant human antibodies, nucleic acids encoding same and methods of use.
ZA973701B (en)	1998-02-04	Vaccines for treatment of lymphoma and leukemia.
IL134480A0 (en)	2001-04-30	Kay - an immune system protein and dna sequences encoding the same
ZA93226B (en)	1994-07-13	Abrasive articles including a crosslinked siloxane, and methods of making and using same.
HUP9902867A3 (en)	2001-12-28	Therapeutic use of vegf protein or nucleic acid coding same and implant, especially for the treatment of intimal hyperplasia
EP0610444A4 (en)	1995-05-17	Method of treating viral diseases.
EP0578819A4 (en)	1994-10-12	Icam-related protein.
WO1995003328A3 (en)	1995-03-16	Melanoma-inhibiting protein
EP0608546A3 (en)	1995-09-27	Glia activating factor (gaf), antibodies against it and their uses.
ZA979731B (en)	1998-04-29	Treatment of asthma.
GR3022569T3 (en)	1997-05-31	The treatment of meat.
EP0647138A4 (en)	1996-03-06	Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same.
NZ229679A (en)	1991-11-26	Recombinant dna sequence encoding an emeria peptide, the peptide and poultry vaccine against coccidiosis
OA09664A (en)	1993-05-15	Virus/herbicide-resistance genes, processes for the preparation thereof and the use thereof
IL98273A0 (en)	1992-06-21	Dna sequences,proteins having esterase activity coded by them,and use of such proteins
EP0586065A3 (en)	1994-09-28	Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
EP0472399A3 (en)	1993-07-14	Hla-dr antigen gene, its nucleotide sequence and its use
EP0227604A3 (en)	1989-01-18	Use of oligopeptides in the treatment of viral infections
NO903801D0 (en)	1990-08-30	ALKALIPULLUNASE, MICROORGANISM AND PROCEDURES IN THE PREPARATION OF IT.
GB9421093D0 (en)	1994-12-07	Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof